These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 3190011)

  • 21. Treatment of paediatric visceral leishmaniasis: amphotericin B or pentavalent antimony compounds?
    Kafetzis DA; Velissariou IM; Stabouli S; Mavrikou M; Delis D; Liapi G
    Int J Antimicrob Agents; 2005 Jan; 25(1):26-30. PubMed ID: 15620822
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of visceral leishmaniasis with meglumine and allopurinol.
    Ragusa R; Di Cataldo A; Samperi P; Schiliro G
    Am J Dis Child; 1993 Jun; 147(6):611-2. PubMed ID: 8506827
    [No Abstract]   [Full Text] [Related]  

  • 23. [Cutaneous leishmaniasis: treatment with cryotherapy and intramuscular injections of meglumine antimonate (glucantime)].
    Rzany B; Krutmann J; Goerttler E; Schöpf E
    Hautarzt; 1990 Feb; 41(2):98-101. PubMed ID: 2318646
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of cutaneous leishmaniasis recidivans with a combination of allopurinol and meglumine antimoniate: a clinical and histologic study.
    Esfandiarpour I; Dabiri SH
    Int J Dermatol; 2007 Aug; 46(8):848-52. PubMed ID: 17651170
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Our experiences in visceral leishmaniasis therapy.
    Titone L; Scarlata F; Cascio A; Giordano S; Mancuso G
    J Chemother; 1989 Jul; 1(4 Suppl):960-1. PubMed ID: 16312722
    [No Abstract]   [Full Text] [Related]  

  • 26. Cytogenetic observations after meglumine antimoniate therapy for visceral leishmaniasis.
    Hantson P; Léonard ED; Crutzen-Fayt MC; Léonard A; Vandercam B; Delaere B; Mahieu P
    Pharmacotherapy; 1996; 16(5):869-71. PubMed ID: 8888081
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Apparent Glucantime failure in five patients with mucocutaneous leishmaniasis.
    Rocha RA; Sampaio RN; Guerra M; Magalhâes A; Cuba CC; Barreto AC; Marsden PD
    J Trop Med Hyg; 1980 Aug; 83(4):131-9. PubMed ID: 6997505
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Meglumine antimoniate-induced pancreatitis.
    Torrús D; Massa B; Boix V; Portilla J; Pérez-Mateo M
    Am J Gastroenterol; 1996 Apr; 91(4):820-1. PubMed ID: 8677970
    [No Abstract]   [Full Text] [Related]  

  • 29. Characterization of circulating lymphocyte subpopulations in canine leishmaniasis throughout treatment with antimonials and allopurinol.
    Miranda S; Martorell S; Costa M; Ferrer L; Ramis A
    Vet Parasitol; 2007 Mar; 144(3-4):251-60. PubMed ID: 17110042
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antileishmanial activity of selected compounds in dogs experimentally infected with Leishmania donovani.
    Chapman WL; Hanson WL; Waits VB; Kinnamon KE
    Rev Inst Med Trop Sao Paulo; 1979; 21(4):189-93. PubMed ID: 545640
    [No Abstract]   [Full Text] [Related]  

  • 31. Variation of proteinuria in dogs with leishmaniasis treated with meglumine antimoniate and allopurinol: a retrospective study.
    Pierantozzi M; Roura X; Paltrinieri S; Poggi M; Zatelli A
    J Am Anim Hosp Assoc; 2013; 49(4):231-6. PubMed ID: 23690493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunologic tests in patients after clinical cure of visceral leishmaniasis.
    De Almeida Silva L; Romero HD; Prata A; Costa RT; Nascimento E; Carvalho SF; Rodrigues V
    Am J Trop Med Hyg; 2006 Oct; 75(4):739-43. PubMed ID: 17038704
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atypical disseminated leishmaniasis resembling post-kala-azar dermal leishmaniasis in an HIV-infected patient.
    Boumis E; Chinello P; Della Rocca C; Paglia MG; Proietti MF; Petrosillo N
    Int J STD AIDS; 2006 May; 17(5):351-3. PubMed ID: 16643688
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amphotericin B lipid complex versus meglumine antimoniate in the treatment of visceral leishmaniasis in patients infected with HIV: a randomized pilot study.
    Laguna F; Videla S; Jiménez-Mejías ME; Sirera G; Torre-Cisneros J; Ribera E; Prados D; Clotet B; Sust M; López-Vélez R; Alvar J;
    J Antimicrob Chemother; 2003 Sep; 52(3):464-8. PubMed ID: 12888588
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nodular lymphangitic subcutaneous dissemination after intralesional antimonial treatment for localized cutaneous leishmaniasis.
    Yébenes M; Cruz I; Cañavate C; Gilaberte M; Baena V; Pujol RM
    Clin Exp Dermatol; 2008 Mar; 33(2):142-4. PubMed ID: 18076691
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pediatric visceral leishmaniasis in Western Sicily, Italy: a retrospective analysis of 111 cases.
    Cascio A; Colomba C; Antinori S; Orobello M; Paterson D; Titone L
    Eur J Clin Microbiol Infect Dis; 2002 Apr; 21(4):277-82. PubMed ID: 12072938
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isolation of Leishmania tropica from a patient with visceral leishmaniasis and disseminated cutaneous leishmaniasis, southern Iran.
    Alborzi A; Pouladfar GR; Fakhar M; Motazedian MH; Hatam GR; Kadivar MR
    Am J Trop Med Hyg; 2008 Sep; 79(3):435-7. PubMed ID: 18784238
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute phase proteins and plasma lipoproteins during antimony treatment in infantile visceral leishmaniasis.
    Kallel R; Bekaert ED; Dubois DY; Alcindor LG; Ayrault-Jarrier M; Mebazza A
    Clin Physiol Biochem; 1993; 10(1):8-12. PubMed ID: 8339522
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effectiveness of Short-Course Meglumine Antimoniate (Glucantime®) for Treatment of Visceral Leishmaniasis: A 13-Year, Multistage, Non-Inferiority Study in Iran.
    Alborzi A; Pouladfar G; Attar A; Falahi F; Jafarpour Z; Karimi A; Kadivar MR
    Am J Trop Med Hyg; 2017 Jan; 96(1):182-189. PubMed ID: 27879460
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of renal and hepatic functions in dogs naturally infected by visceral leishmaniasis submitted to treatment with meglumine antimoniate.
    Ikeda-Garcia FA; Lopes RS; Ciarlini PC; Marques FJ; Lima VM; Perri SH; Feitosa MM
    Res Vet Sci; 2007 Aug; 83(1):105-8. PubMed ID: 17150234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.